Early Triple Negative Breast Cancer
2 clinical trials · Condition
◉ Watch Early Triple Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003) (NCT06829199) | Merck Sharp & Dohme LLC | 2025-03-26 |
| BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy (NCT01672671) | Russian Academy of Medical Sciences | 2011-08-01 |
Track Early Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.